Reply to Karabay and Karabay
Clin Infect Dis
.
2019 Mar 19;68(7):1252-1253.
doi: 10.1093/cid/ciy886.
Authors
Vlad Dragan
1
,
Yanliang Wei
1
,
Marion Elligsen
2
3
,
Jerome A Leis
1
4
5
6
Affiliations
1
Department of Medicine, University of Toronto, Ontario, Canada.
2
Department of Pharmacy, Sunnybrook Health Sciences Centre, Ontario, Canada.
3
Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada.
4
Division of Infectious Diseases and General Internal Medicine, Sunnybrook Health Sciences Centre, Ontario, Canada.
5
Sunnybrook Research Institute and Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada.
6
Centre for Quality Improvement and Patient Safety and Department of Medicine, University of Toronto, Ontario, Canada.
PMID:
30321296
DOI:
10.1093/cid/ciy886
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents
Anti-Infective Agents*
Humans
Pneumonia*
Pneumonia, Aspiration*
Substances
Anti-Bacterial Agents
Anti-Infective Agents